ImmunityBio, Inc. IBRX

https://finance.yahoo.com/sectors/healthcare/articles/anktiva-strong-demand-propels-immunitybio-182923295.html

Dr PSS learned his lesson to be quiet unless official news release or the parasitic class action scum file lawsuits

Paul Silberberg please
Send us your thoughts

550,000 shares average cost $5.48

Never sold a single share and won't.....

Why why would I share price will be way higher in 1-2-3-4-5 years I may sell some in 5 years

I bought added 50,000 at 9.22 and haven't thought oh I could have bought at 7
Why? In 2-5 years is will be $20-$100

Dr PSS is never selling ImmunityBio

So tired of talk about shorts and charts and resistance at this that price range.

None of this affects 1-2-3-4-5 years

The sick parasitic class action lawsuits are chasing shareholders. The shareholders to claim losses would have had to realize them. Paper losses don't qualify. That's why they're soliciting so hard to find people that actually bought and sold and lost. Hope all class action lawsuit attorneys rot in hell...... forever love most people I love most people hate class action lawyers

The more I think about it. I think the FDA is doing more than protecting Big Pharma and Keytruda and Merck. They are slow balling ImmunityBio, IBRX, Anktiva to save the government money and the insurance carriers. Anktiva could potentially be used with all other cancer therapies including the new immunotherapies plus treating Lymphopenia. Clearing spike proteins goes on and on..... Think of the costs to Medicare, Medicaid and all healthcare insurance. Billions. Could be 100 billion or more.

Poorofftrading

If it goes to $21 550,000x$16 gain = I profit 8.8 million

I believe IBRX will go to $25 $50 $75 and over $100